Archive: 10/26/2009

GAO: FDA fails to follow up on unproven drugs

(AP) -- The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators.

Oct 26, 2009
not rated yet 0